Trials / Unknown
UnknownNCT05474781
Eliminating HCV Infection Among PWUD
Micro-elimination of HCV Infection Among People Who Use Drug (PWUD) in British.Columbia: A Comprehensive, Multidisciplinary, Scalable Programmatic Approach
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Vancouver Infectious Diseases Centre · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
Identify 300 PWUD with chronic, viremic HCV infection and engage them in a multidisciplinary, generalizable model of care and initiate HCV treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Epclusa | HCV treatment |
Timeline
- Start date
- 2019-02-22
- Primary completion
- 2023-12-31
- Completion
- 2024-12-31
- First posted
- 2022-07-26
- Last updated
- 2022-07-26
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05474781. Inclusion in this directory is not an endorsement.